| Literature DB >> 32279715 |
Christine M Stahl1, Andrew Feigin2.
Abstract
Huntington disease, a neurodegenerative disease characterized by progressive motor, behavioral, and cognitive decline, is caused by a CAG trinucleotide repeat expansion in the huntingtin gene on chromosome 4. Current treatments target symptom management because there are no disease-modifying therapies at this time. Investigation of RNA-based and DNA-based treatment strategies are emerging and hold promise of possible future disease-modifying therapy.Entities:
Keywords: Antipsychotic drugs; Antisense oligonucleotides; Deep brain stimulation; Huntington disease; Vesicular monoamine transporter type 2 inhibitors
Year: 2020 PMID: 32279715 DOI: 10.1016/j.ncl.2020.01.010
Source DB: PubMed Journal: Neurol Clin ISSN: 0733-8619 Impact factor: 3.806